Optic

Optic Inc., an AI drug discovery company, are the creators of Bioptic.io — a proprietary ligand-based molecular search AI. Bioptic identifies small molecules by their activity-expressing fingerprints, assisting drug hunters in discovering a diverse set of candidates.